loadpatents
Patent applications and USPTO patent grants for de Graaff; Wouter.The latest application filed is for "drug delivery system for delivery of anti-virals".
Patent | Date |
---|---|
Drug delivery system for delivery of anti-virals Grant 10,596,103 - Aarts , et al. | 2020-03-24 |
Intravaginal ring drug delivery system Grant 10,413,504 - de Graaff , et al. Sept | 2019-09-17 |
Drug Delivery System For Delivery Of Anti-virals App 20160296467 - Aarts; Dennis ;   et al. | 2016-10-13 |
Macrocyclic lactone drug delivery system Grant 9,345,686 - De Graaff , et al. May 24, 2 | 2016-05-24 |
Zoo-Technical Drug Delivery Device App 20160038430 - Driancourt; Marc-Antoine ;   et al. | 2016-02-11 |
Growth promotion of animals by simultaneous release of steroid compounds from a device Grant 9,198,857 - De Graaff , et al. December 1, 2 | 2015-12-01 |
Intrauterine Deposit App 20150335464 - de Graaff; Wouter ;   et al. | 2015-11-26 |
Drug Delivery System App 20150157561 - de Graaff; Wouter ;   et al. | 2015-06-11 |
Drug delivery system Grant 8,900,615 - Groenewegen , et al. December 2, 2 | 2014-12-02 |
Drug delivery system Grant 8,858,977 - Groenewegen , et al. October 14, 2 | 2014-10-14 |
Drug delivery system based on polyethylene vinylacetate copolymers Grant 8,808,744 - de Graaff , et al. August 19, 2 | 2014-08-19 |
Drug delivery system Grant 8,741,329 - de Graaff , et al. June 3, 2 | 2014-06-03 |
X-ray visible drug delivery device Grant 8,722,037 - Veenstra , et al. May 13, 2 | 2014-05-13 |
Drug Delivery System App 20140056962 - de Graaff; Wouter ;   et al. | 2014-02-27 |
Intrauterine system Grant 8,568,374 - De Graaff , et al. October 29, 2 | 2013-10-29 |
Drug delivery system based on polyethylene vinylacetate copolymers Grant 8,481,079 - De Graaff , et al. July 9, 2 | 2013-07-09 |
Drug Delivery System App 20130115265 - Groenewegen; Rudolf Johannes Joseph ;   et al. | 2013-05-09 |
Drug Delivery System App 20130078286 - Groenewegen; Rudolf Johannes Joseph ;   et al. | 2013-03-28 |
Drug delivery system Grant 8,333,983 - Groenewegen , et al. December 18, 2 | 2012-12-18 |
Intrauterine deposit Grant 8,291,910 - de Graaff , et al. October 23, 2 | 2012-10-23 |
Zoo-technical Drug Delivery Device App 20120058171 - De Graaff; Wouter ;   et al. | 2012-03-08 |
Macrocyclic Lactone Drug Delivery System App 20120052108 - De Graaff; Wouter ;   et al. | 2012-03-01 |
Intrauterine Deposit App 20110017219 - de Graaff; Wouter ;   et al. | 2011-01-27 |
Intrauterine System App 20100280464 - De Graaff; Wouter ;   et al. | 2010-11-04 |
Delivery System For Risperidone App 20100203104 - De Graaff; Wouter ;   et al. | 2010-08-12 |
Vaginal Delivery System For Mirtazapine App 20100129425 - De Graaff; Wouter ;   et al. | 2010-05-27 |
Delivery System For A Non-steroidal Non-ionized Hydrophilic Drug App 20100104619 - De Graaff; Wouter ;   et al. | 2010-04-29 |
Drug Delivery System App 20090081278 - De Graaff; Wouter ;   et al. | 2009-03-26 |
X-Ray Visible Drug Delivery Device App 20080112892 - Veenstra; Harm ;   et al. | 2008-05-15 |
Drug delivery system based on polyethylene vinylacetate copolymers App 20070141102 - De Graaff; Wouter ;   et al. | 2007-06-21 |
Drug delivery system App 20060280771 - Groenewegen; Rudolf Johannes Joseph ;   et al. | 2006-12-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.